Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2014
04/23/2014CN103735516A Microspheres including oxidized cellulose
04/23/2014CN103735515A Polymer formulations of cetp inhibitors
04/23/2014CN103735514A Polyethylene glycol vitamin E succinate and calprotectin modified nanoparticle and preparation method thereof
04/23/2014CN103735513A 20(s)-protopanoxadiol nano-particle and preparation method thereof
04/23/2014CN103735512A Enrofloxacin solid dispersion and preparation method thereof
04/23/2014CN103735511A Preparation method of magnetic drug-carrying liposome
04/23/2014CN103735506A Extraction preparation of unilamelar liposome
04/23/2014CN103735504A Irinotecan nano lipid binding preparation and preparation method thereof
04/23/2014CN103735502A In-situ gel injection containing non-steroidal anti-inflammatory medicament/hydrogenated castor oil
04/23/2014CN103735501A CS/GP/MAX (Methotrexate-loaded Chitosan-based Thermosensitive Hydrogel) and application thereof
04/23/2014CN103735497A Liquiritigenin injection and preparation method and application thereof
04/23/2014CN103735496A Compound nasal gel for treating allergic rhinitis and preparing method thereof
04/23/2014CN103735494A External antipruritic ointment for treating mosquito bite and preparation method of external antipruritic ointment
04/23/2014CN103735493A Palmatine vaginal swelling bolt as well as preparation method and detection method thereof
04/23/2014CN103735492A Progesterone vaginal expansive suppository as well as preparation method and detection method thereof
04/23/2014CN103735491A Clindamycin phosphate vaginal expansive suppository as well as preparation method and detection method thereof
04/23/2014CN103735490A Method for preparing medicament sustained-release material
04/23/2014CN103735460A Natural plant essential oil fruit and preparation method thereof
04/23/2014CN103054834B Preparation method of nimodipine self-microemulsion osmotic pump controlled-release capsule
04/23/2014CN103007289B Heat-resisting protective agent for duck virus hepatitis live vaccines and preparation method and application of protective agent
04/23/2014CN102988434B Centella effective extractive polyethylene glycol ointment and preparation method thereof
04/23/2014CN102977384B Modification method and application of cellulosa-imitating film structure of polylactic acid nano-particle surface
04/23/2014CN102961753B Copper sulfide/mesoporous silicon dioxide core-shell nano material as well as preparation method and application thereof
04/23/2014CN102908326B Asparagine tablet and preparation method thereof
04/23/2014CN102861040B Medicine composition containing aspirin, acetaminophen and caffeine and preparation method thereof
04/23/2014CN102805869B Folic acid functionalized drug-loaded mesoporous silica and preparation method thereof
04/23/2014CN102796235B Copolymer based on environmental response and preparation method thereof
04/23/2014CN102786695B Amphiphilic triblock copolymer, preparation method and siRNA drug carrier
04/23/2014CN102755292B Vesicle-type medication system containing metformin, and application thereof
04/23/2014CN102716495B Multifunctional poly(malic acid) carried drug for targeting treatment of tumors
04/23/2014CN102716492B Baicalin hydroxypropyl-beta-cyclodextrin inclusion compound as well as preparation method and application thereof
04/23/2014CN102697705B Liposome gel preparation and preparation method and application thereof
04/23/2014CN102585013B Fusion protein containing omega interferon and method for preparing same
04/23/2014CN102552916B New use of sodium salicylate
04/23/2014CN102342931B Injectable parenteral medicinal preparation of temozolomide and preparation method thereof
04/23/2014CN102302443B Misoprostol vaginal sustained-release suppository and preparation method thereof
04/23/2014CN101940695B Chinese medicinal ointment for treating vitiligo and preparation method thereof
04/23/2014CN101616691B Multimeric conjugate
04/23/2014CN101534844B Liquid chalcogenide compositions and methods of manufacturing and using the same
04/23/2014CN101325968B Anti-CTLA-4 antibody compositions
04/22/2014US8703924 Chitosan composition
04/22/2014US8703878 High-molecular weight conjugate of steroids
04/22/2014US8703820 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
04/22/2014US8703818 Compositions and methods comprising C16:1n7-palmitoleate
04/22/2014US8703722 Inhibitors of F18+ E coli binding
04/22/2014US8703714 Monomethylvaline compounds capable of conjugation to ligands
04/22/2014US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
04/22/2014US8703427 Biological materials and uses thereof
04/22/2014US8703199 Pharmaceutical compositions of adsorbates of amorphous drug
04/22/2014US8703197 Branched polyamines for delivery of biologically active materials
04/22/2014US8703196 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
04/22/2014US8703195 Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof
04/22/2014US8703189 Medicinal composition
04/22/2014US8703185 Stable pharmaceutical composition and methods of using same
04/22/2014US8703173 Newborn infant formulas and feeding methods
04/22/2014US8703172 Sphingolipids for improvement of the composition of the intestinal flora
04/22/2014US8703155 Method of stabilizing reduced coenzyme q10
04/22/2014US8703152 Methods of treating inflammatory intestinal disease and managing symptoms thereof
04/22/2014CA2830275A1 Omega 3-fatty acid emulsion
04/22/2014CA2728202C Composition for addition to drinking water
04/22/2014CA2712170C Stable pharmaceutical composition
04/22/2014CA2671676C Von willebrand factor-and factor viii-polymer conjugates having a releasable linkage
04/22/2014CA2641570C Stabilization of solid thyroid drug formulations
04/22/2014CA2618705C Improved delivery of tetrahydrocannabinol
04/22/2014CA2613355C A direct drug delivery system based on thermally responsive biopolymers
04/22/2014CA2611451C Solid preparation
04/22/2014CA2585855C Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent
04/22/2014CA2534897C Process of making flowable hemostatic compositions and devices containing such compositions
04/17/2014WO2014059430A1 Delivery of small interfering rna and micro rna through membrane-disruptive, responsive nanoscalle hydrogels
04/17/2014WO2014059363A1 Oral solution formulations of aripiprazole
04/17/2014WO2014059309A1 Pharmaceutical formulations of pilocarpine
04/17/2014WO2014059284A1 Method of preparing resin tinctures
04/17/2014WO2014059245A1 Compositions and methods for sustained delivery of glucagon-like peptide (glp-1) receptor agonist therapeutics
04/17/2014WO2014059244A1 Silk reservoirs for sustained delivery of anti-cancer agents
04/17/2014WO2014059022A1 Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
04/17/2014WO2014058947A1 Compositions and methods for treating cancer using pi3k inhibitor and anti-cd19 maytansinoid immunoconjugate
04/17/2014WO2014058329A1 Compositions based on hypophyseal hormones for adding to infusion fluids
04/17/2014WO2014058179A2 Low-density lipoprotein analogue nanoparticles, and composition comprising same for targeted diagnosis and treatment of liver
04/17/2014WO2014058079A1 Electrostatic-bonding-type vesicle including metal microparticles
04/17/2014WO2014058046A1 Pharmaceutical preparation containing calcium antagonist/angiotensin ii receptor antagonist
04/17/2014WO2014057966A1 Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same
04/17/2014WO2014057928A1 Skin patch
04/17/2014WO2014057432A2 Multicomponent lipid nanoparticles and processes for the preparation thereof
04/17/2014WO2014057365A1 Stable injectable pharmaceutical composition of epinephrine or salts thereof
04/17/2014WO2014057122A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
04/17/2014WO2014057120A1 Pyrrolobenzodiazepine-antibody conjugates
04/17/2014WO2014057119A1 Pyrrolobenzodiazepine-antibody conjugates
04/17/2014WO2014057118A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
04/17/2014WO2014057117A1 Pyrrolobenzodiazepine-antibody conjugates
04/17/2014WO2014057115A1 Pyrrolobenzodiazepine-anti-her2 antibody conjugates
04/17/2014WO2014057114A1 Pyrrolobenzodiazepine-anti-psma antibody conjugates
04/17/2014WO2014057113A1 Pyrrolobenzodiazepine - anti-psma antibody conjugates
04/17/2014WO2014057096A1 Composition for alleviating conditions associated with vaginal dryness
04/17/2014WO2014057074A1 Pyrrolobenzodiazepines and conjugates thereof
04/17/2014WO2014057073A1 Pyrrolobenzodiazepines and conjugates thereof
04/17/2014WO2014057072A1 Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
04/17/2014WO2014057067A1 Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms
04/17/2014WO2014057043A1 Composition and delivery vehicle for active agents and methods therefor
04/17/2014WO2014056941A1 Use of moisture-conditioned disintegrants in tablet manufacture
04/17/2014WO2014056926A1 Hydrogel prodrugs
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 1712